The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
INDI: a computational framework for inferring drug interactions and their associated recommendations
Open accessAbstract
Inferring drug-drug interactions (DDIs) is an essential step in drug development and drug administration. Most computational inference methods focus on modeling drug pharmacokinetics, aiming at interactions that result from a common metabolizing enzyme (CYP). Here, we introduce a novel prediction method, INDI (INferring Drug Interactions), allowing the inference of both pharmacokinetic, CYP-related DDIs (along with their associated CYPs) and pharmacodynamic, non-CYP associated ones. On cross validation, it obtains high specificity and sensitivity levels (AUC (area under the receiver-operating characteristic curve) ≥0.93). In application to the FDA adverse event reporting system, 53% of the drug events could potentially be connected to known (41%) or predicted (12%) DDIs. Additionally, INDI predicts the severity level of each DDI upon co-administration of the involved drugs, suggesting that severe interactions are abundant in the clinical practice. Examining regularly taken medications by hospitalized patients, 18% of the patients receive known or predicted severely interacting drugs and are hospitalized more frequently. Access to INDI and its predictions is provided via a web tool at http://www.cs.tau.ac.il/~bnet/software/INDI, facilitating the inference and exploration of drug interactions and providing important leads for physicians and pharmaceutical companies alike.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Nouvelles recherches sur la distribution florale
Jaccard, P. (1908) · E-Periodica · doi:10.5169/seals-268384 · Cited by 3,316
Towards a proteome-scale map of the human protein–protein interaction network
Rual, J.-F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005) · Nature · doi:10.1038/nature04209 · Cited by 2,933
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome
Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F. H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.029 · Cited by 2,387
KEGG for representation and analysis of molecular networks involving diseases and drugs
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322
Resnik, P. (1999) · Journal of Artificial Intelligence Research · doi:10.1613/jair.514 · Cited by 2,047
Xenarios, I. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.303 · Cited by 1,741
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models
Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997) · Toxicology and Industrial Health · doi:10.1177/074823379701300401 · Cited by 1,415
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
The BioGRID interaction database: 2013 update
Chatr-aryamontri, A., Breitkreutz, B.-J., Heinicke, S., Boucher, L., Winter, A., Stark, C., Nixon, J., Ramage, L., Kolas, N., O’Donnell, L., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1158 · Cited by 1,017
Large‐scale mapping of human protein–protein interactions by mass spectrometry
Ewing, R. M., Chu, P., Elisma, F., Li, H., Taylor, P., Climie, S., McBroom‐Cerajewski, L., Robinson, M. D., O'Connor, L., Li, M., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100134 · Cited by 984
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936
Quantitative signal detection using spontaneous ADR reporting
Bate, A., & Evans, S. J. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1742 · Cited by 912
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Self-citationThe BioGRID Interaction Database: 2011 update
Stark, C., Breitkreutz, B.-J., Chatr-aryamontri, A., Boucher, L., Oughtred, R., Livstone, M. S., Nixon, J., Van Auken, K., Wang, X., Shi, X., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1116 · Cited by 854
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A., & Redelmeier, D. A. (2003) · JAMA · doi:10.1001/jama.289.13.1652 · Cited by 761
Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
Zhou, S.-F. (2008) · Current Drug Metabolism · doi:10.2174/138920008784220664 · Cited by 719
Drug Synergism: Its Detection and Applications
Tallarida, R. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29450-7 · Cited by 687
Ingelman-Sundberg, M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.007 · Cited by 676
SuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Infrastructure for the life sciences: design and implementation of the UniProt website
Jain, E., Bairoch, A., Duvaud, S., Phan, I., Redaschi, N., Suzek, B. E., Martin, M. J., McGarvey, P., & Gasteiger, E. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-136 · Cited by 484
Steinbeck, C., Hoppe, C., Kuhn, S., Floris, M., Guha, R., & Willighagen, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585274 · Cited by 462
Obach, R. S., Walsky, R. L., & Venkatakrishnan, K. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012633 · Cited by 460
Hepatotoxicity of Chemotherapy
King, P. D., & Perry, M. C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-162 · Cited by 454
Bertilsson, L. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529030-00005 · Cited by 432
Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
Riechelmann, R. P., Tannock, I. F., Wang, L., Saad, E. D., Taback, N. A., & Krzyzanowska, M. K. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk130 · Cited by 328
Distance matters: a population based study examining access to maternity services for rural women
Grzybowski, S., Stoll, K., & Kornelsen, J. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-147 · Cited by 278
Preissner, S., Kroll, K., Dunkel, M., Senger, C., Goldsobel, G., Kuzman, D., Guenther, S., Winnenburg, R., Schroeder, M., & Preissner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp970 · Cited by 274
Predicting Drug–Drug Interactions: An FDA Perspective
Zhang, L., Zhang, Y., Zhao, P., & Huang, S.-M. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9106-3 · Cited by 267
Combining Drug and Gene Similarity Measures for Drug-Target Elucidation
Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0213 · Cited by 218
Self-citationTatonetti, N. P., Fernald, G. H., & Altman, R. B. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000214 · Cited by 203
The statistical distribution of nucleic acid similarities
Smith, T. F., Waterman, M. S., & Burks, C. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.2.645 · Cited by 203
Models from experiments: combinatorial drug perturbations of cancer cells
Nelander, S., Wang, W., Nilsson, B., She, Q., Pratilas, C., Rosen, N., Gennemark, P., & Sander, C. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.53 · Cited by 187
Fowler, S., & Zhang, H. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9042-7 · Cited by 180
Modeling and predicting drug pharmacokinetics in patients with renal impairment
Rowland Yeo, K., Aarabi, M., Jamei, M., & Rostami-Hodjegan, A. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.143 · Cited by 159
In silico prediction of ADME and pharmacokinetics
Boobis, A. R., Gundert‐Remy, U., Kremers, P. G., Macheras, P. E., & Pelkonen, O. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00185-9 · Cited by 156
Spontaneous reporting of adverse drug reactions. I: the data.
Rawlins, M. D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03356.x · Cited by 150
van der Heijden, P. G. M., van Puijenbroek, E., van Buuren, S., & van der Hofstede, J. W. (2002) · Statistics in Medicine · doi:10.1002/sim.1157 · Cited by 136
Towards a mechanism-based analysis of pharmacodynamic drug?drug interactions in vivo
Jonker, D. M., Visser, S. A. G., VANDERGRAAF, P., Voskuyl, R. A., & Danhof, M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.014 · Cited by 134
An Algorithmic Framework for Predicting Side Effects of Drugs
Atias, N., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0255 · Cited by 131
Self-citationDoubova, S. V., Reyes‐Morales, H., Torres‐Arreola, L. D. P., & Suárez-Ortega, M. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-147 · Cited by 128
Designing better drugs: predicting cytochrome P450 metabolism
de Groot, M. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.001 · Cited by 122
WOMBAT: World of Molecular Bioactivity
Olah, M., Mracec, M., Halip, L., Rad-Curpăn, R., Bora, A., Hadaruga, N. G., Olah, I., Banda, M., Simon, Z., Mracec, M., et al. (2005) · Methods and principles in medicinal chemistry · doi:10.1002/3527603743.ch9 · Cited by 117
Fast Gene Ontology based clustering for microarray experiments
Ovaska, K., Laakso, M., & Hautaniemi, S. (2008) · BioData Mining · doi:10.1186/1756-0381-1-11 · Cited by 109
DCDB: Drug combination database
Liu, Y., Hu, B. X., Cheng‐Xin, F. U., & Chen, X. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp697 · Cited by 97
Chemogenomic profiling predicts antifungal synergies
Jansen, G., Lee, A. Y., Epp, E., Fredette, A., Surprenant, J., Harcus, D., Scott, M. S., Tan, E., Nishimura, T., Whiteway, M. S., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.95 · Cited by 80
Škrbo, A., Begović, B., & Škrbo, S. (2004) · PubMed · Cited by 76
Application of in silico approaches to predicting drug–drug interactions
Ekins, S., & Wrighton, S. A. (2001) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(01)00119-8 · Cited by 73
Jacqz-Aigrain, É., Bessa, E., Médard, Y., Mircheva, Y., & VILMER, E. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04314.x · Cited by 63
Obach, R. S. (2009) · PubMed · Cited by 56
Spontaneous Reporting of Adverse Drug Reactions
Rawlins, M. D. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a067980 · Cited by 54
Manzi, S. F., & Shannon, M. W. (2005) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2005.04.006 · Cited by 46
Application of mechanism-based CYP inhibition for predicting drug–drug interactions
Zhou, Z.-W., & Zhou, S.-F. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902926099 · Cited by 46
Evaluation of Methods for Predicting Drug-drug Interactions by Monte Carlo Simulation
Kato, M., Tachibana, T., Ito, K., & Sugiyama, Y. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.121 · Cited by 26
Crowther, N. R., Holbrook, A. M., Kenwright, R., & Kenwright, M. (1997) · PubMed Central · Cited by 22
An Algorithmic Framework for Predicting Side-Effects of Drugs
Atias, N., & Sharan, R. (2010) · Lecture notes in computer science · doi:10.1007/978-3-642-12683-3_1 · Cited by 17
Self-citation(2001) · doi:10.1002/pds.4850 · Cited by 7
Cited by
Modeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Deep learning improves prediction of drug–drug and drug–food interactions
Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803294115 · Cited by 655
Jarada, T. N., Rokne, J. G., & Alhajj, R. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00450-7 · Cited by 384
Zhang, W., Chen, Y., Liu, F., Luo, F., Tian, G., & Li, X. (2017) · BMC Bioinformatics · doi:10.1186/s12859-016-1415-9 · Cited by 356
Metadata
- Authors
- Gottlieb, A., Stein, G. Y., Oron, Y., Ruppin, E., & Sharan, R.
- Venue
- Molecular Systems Biology
- Published
- 2012-01
- Volume
- 8
- Issue
- 1
- Pages
- 592-592
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W2109482131
- Cited by
- 277
- References
- 66
- FWCI
- 12.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.